Target intelligence / Profile preview

MF59-Adjuvant Enhanced Immune System (MF59-Adjuvant)

Target
MF59-Adjuvant
Molecular classification
Adjuvant, Emulsion
01

Overview

MF59 is an oil-in-water emulsion adjuvant used in vaccines to enhance the immune response. It acts broadly on the immune system, primarily by modulating innate and adaptive immunity at the site of vaccine administration. Its main function is to boost both the magnitude and quality of immune responses to co-administered antigens, leading to higher antibody titers, affinity maturation, and cross-protection.

Other names
MF59 adjuvantMF59-adjuvanted immune response
02

Mechanism of action

MF59 rapidly induces local production of chemokines (e.g., CCL2/MCP-1, CCL3/MIP-1α, CCL4/MIP-1β, CXCL8/IL-8) at the injection site leading to recruitment of innate immune cells. It enhances antigen uptake and presentation by APCs (neutrophils, monocytes, dendritic cells). It promotes dendritic cell differentiation in draining lymph nodes and increases activation of CD4+ T follicular helper (Tfh) cells in germinal centers leading to increased antibody affinity maturation and higher titers.

03

Biological functions

Immune response enhancementInnate immune activationAdaptive immune activationAntigen presentationDendritic cell maturationAntibody productionT cell activationB cell activation
04

Disease associations

InfectionVaccine development
05

Safety considerations

Injection site reactions (pain, redness, swelling)Systemic reactions (fever, fatigue, myalgia) - typically mild and transient
06

Interacting drugs

Influenza vaccines (MF59-adjuvanted)
07

Biomarkers

HAI titers (antibody levels)Chemokine levels (CCL2, CCL3, CCL4, CCL8)Memory T/B cell populations

Beyond the preview

Go deeper on MF59-Adjuvant Enhanced Immune System (MF59-Adjuvant).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MF59-Adjuvant Enhanced Immune System (MF59-Adjuvant).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call